Susquehanna Portfolio Strategies, LLC Myriad Genetics Inc Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 456,140 shares of MYGN stock, worth $2.87 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
456,140Holding current value
$2.87 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
234Shares Held
94.6MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$95.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.88MShares$49.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$31 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$30.3 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$28.9 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $508M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...